FIELD: medicine.
SUBSTANCE: present invention refers to medicine, namely to a pharmaceutical composition for parenteral drop introduction, intended for treating cardiovascular diseases, which is characterized by that it contains a complex of active substances, with the following ratio of components: thiamine pyrophosphate 50 mg; adenosine triphosphate disodium hydrate 20 mg; polyenylphosphatidylcholine 1,250–2,500 mg; phosphatidylserine 200–400 mg; monoammonium glycyrrhizinate (in terms of glycyrrhizic acid) 13.25 (10) mg; L-carnitine 250 mg; L-arginine hydrochloride 100 mg; L-citrulline 100 mg; L-ornithine 100 mg; inosine 200 mg; nicotinamide adenine dinucleotide phosphate 100 mg; dexpanthenol 100 mg; ubedecarenone 25 mg; Gingko Biloba extract 17.5 mg; magnesium sulphate hydrate 1.23 g; ascorbic acid 1,000–2,000 mg; 8 % aqueous solution of benzyl alcohol 50 ml; distilled water up to 500 ml.
EFFECT: present invention provides a wider range of agents for said purpose by creating a highly effective pharmaceutical composition for parenteral drop introduction, which can be used for treating cardiovascular diseases.
1 cl, 3 ex
